Cybin Vs. Lexaria Bioscience Industry Stock Comparison

Buy

51

CYBN
Cybin

Last Price:

9.68

Seasonality Move:

25.56%

Sell

23

LEXX
Lexaria Bioscience

Last Price:

2.07

Seasonality Move:

5.11%

Buy

51

Cybin (CYBN) is a Buy

Is Cybin a Buy, Sell or Hold?

The current Cybin [CYBN] share price is $9.82. The Score for CYBN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
CYBN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

23

Lexaria Bioscience (LEXX) is a Sell

Is Lexaria Bioscience a Buy, Sell or Hold?

The current Lexaria Bioscience [LEXX] share price is $2.09. The Score for LEXX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
LEXX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CYBN Stock Price Chart

What is Cybin's stock price today?

The Cybin share price today is $9.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYBN is experiencing slight buying pressure.

LEXX Stock Price Chart

What is Lexaria Bioscience's stock price today?

The Lexaria Bioscience share price today is $2.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LEXX is experiencing slight selling pressure.

CYBN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.12	Buy
Relative Strength Index (14 RSI):	44.65	Sell
Chaikin Money Flow:	112272	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(10.1 - 11.3)	Sell
Bollinger Bands (100):	(8.98 - 11.12)	Sell

LEXX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.17	Sell
Relative Strength Index (14 RSI):	34.82	Sell
Chaikin Money Flow:	-33987	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(2.11 - 2.55)	Sell
Bollinger Bands (100):	(2.49 - 3.43)	Sell

CYBN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	10.73	Sell
20-day SMA:	10.65	Sell
50-day SMA:	10.02	Sell
200-day SMA:	11.77	Sell
8-day EMA:	10.6	Sell
20-day EMA:	10.63	Sell
50-day EMA:	10.32	Sell
200-day EMA:	11.61	Sell

LEXX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	2.14	Sell
20-day SMA:	2.23	Sell
50-day SMA:	2.72	Sell
200-day SMA:	3.03	Sell
8-day EMA:	2.16	Sell
20-day EMA:	2.29	Sell
50-day EMA:	2.6	Sell
200-day EMA:	2.74	Sell

Cybin Earnings Growth & CYBN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.40 per share, and a decrease next year of $3.04 per share.

Lexaria Bioscience Earnings Growth & LEXX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.09 per share.

Cybin Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lexaria Bioscience Technical Analysis

	Nov 11	Nov 12	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22
	Nov
	11	12	13	14	15	18	19	20	21	22
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):